CLOs on the Move

Terraboost

www.terraboost.com

 
Engage with your audience through hand sanitizing billboards. Terraboost Media has established a network of 52,000 boards throughout the top 130 DMAs in supermarkets, drug stores, shopping malls and airports reaching an audience of over 1.4 billion per month. Brands can literally engage with their audience with a dose of wellness and by selecting the vertical networks and/or zip codes, counties that matter. QR codes, brochures, business reply cards and coupons provide advertisers with means of tracking. Join the over 180 satisfied repeat brands who continue to leverage this engaging media platform of which Arbitron research confirms 63% ad recall ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Medical Supply Corporation

Medical Supply Corporation is a Ferndale, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

AVANCA Medical Devices

AVANCA Medical Devices is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ASI Medical

ASI Medical is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novarix

Novarix is a collaborative medical device development company based near Oxford, UK and Raleigh, North Carolina, USA, delivering innovative new products in the field of venepuncture and cannulation to the worldwide healthcare sector. Novarix are proud to bring to market the IV-eye® – a portable, near infrared (NIR) vein imaging device which demonstrates the company ethos of practicality, simplicity and performance for both healthcare professionals and patients. The product idea came from a nursing perspective and has been developed in consultation with medical professionals in the UK and Denmark and with assistance from the biomedical engineering departments of Oxford University and University College London.

Still River Systems, Inc.

Still River Systems is dedicated to providing physicians and their patients access to high quality, cost-effective proton therapy solutions, and to helping establish this superior treatment modality as a standard of care for patients worldwide.